TrialBMC psychiatry2024

Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning.

Jun Ishigooka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.